The global intravenous immunoglobulin (IVIG) market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Rise in occurrence of immunodeficiency diseases is a key driver for the growth of the global intravenous immunoglobulin (IVIG) market. Additionally, growing adoption of immunoglobulin replacement therapy and increasing global geriatric population in the intravenous immunoglobulin (IVIG) market are some of the other drivers propelling the market growth. Nevertheless, high cost of immunoglobulin therapy, lengthy approval procedures for new technology launches and stringent regulatory framework are expected to restrain the global market growth.
Global Intravenous Immunoglobulin (IVIG) Market Size (USD Billion), 2021-2029
Source: Erevna Healthcare
By Application
Based on application, the market is segmented into myasthenia gravis, hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy, primary immunodeficiency diseases, idiopathic thrombocytopenic purpura (ITP), inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome, and others. In 2021, the hypogammaglobulinemia segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in cases of primary immunodeficiency diseases (PID) worldwide. Chronic inflammatory demyelinating polyneuropathy (CIDP) segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the benefits associated with this segment such as minimally invasive, safe, and user-friendly treatment choices are the major factors driving the market.
By Route of Administration
Based on route of administration, the market is categorized into subcutaneous and intravenous. In 2021, the intravenous segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the major usage of intravenous immunoglobulins in an extensive array of immunology applications worldwide. The subcutaneous segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing in use of subcutaneous IGs for the treatment of PIDs is expected to drive the market.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in awareness related to IVIG product used for treatment of immunodeficiency diseases, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the changing lifestyle with increasing disposable income, growing government and corporate investment in healthcare sector, aged population, and increasing cases of immunodeficiency diseases, are the major factors in this region.
Competitor Insights
Some of the key players in the intravenous immunoglobulin (IVIG) market are Baxter International Inc. (U.S.); Bayer AG (Germany); Biotest AG (Germany); China Biologic Products, Inc. (China); CSL Limited (Australia);Grifols, S.A. (Spain); Kedrion Biopharma Inc. (U.S.); LFB Biotechnologies (France); Octapharma AG (Switzerland); and Takeda Pharmaceutical Company Limited (Japan). The leading players operating in the intravenous immunoglobulin (IVIG) industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The intravenous immunoglobulin (IVIG) market report is categorized into the following segments and subsegments:
Intravenous Immunoglobulin (IVIG) Market, By Application (Revenue, USD Billion, 2021 – 2029)
- Myasthenia Gravis
- Hypogammaglobulinemia
- Chronic Inflammatory demyelinating polyneuropathy (CIDP)
- Multifocal motor neuropathy
- Primary immunodeficiency diseases
- Idiopathic thrombocytopenic purpura (ITP)
- Inflammatory myopathies
- Specific antibody deficiency
- Guillain-Barre syndrome
- Others
Intravenous Immunoglobulin (IVIG) Market, By Route of Administration (Revenue, USD Billion, 2021 – 2029)
- Subcutaneous
- Intravenous
Intravenous Immunoglobulin (IVIG) Market, By Region (Revenue, USD Billion, 2021 – 2029)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Scope of Intravenous Immunoglobulin (IVIG) Market Report:
Key Parameters | Details |
---|---|
Base Year |
|
Forecast Period |
|
Study Coverage |
|
Qualitative Analysis |
|
Regional Market Scope |
|
Company Profiles |
|
15% Free Customization Available |
|
Table of Contents: Intravenous Immunoglobulin (IVIG) Market 2021-2029
- Research Methodology
- Study Objectives
- Study Scope
- Research Assumptions
- Research Framework
- Research Models
- Bottom-up Approach
- Top-down Approach
- Data Triangulation
- Data Procurement
- Internal Database
- Secondary Research
- Purchased Database
- Primary Research
- Data Analysis
- Data Validation
- Market Size Estimation
- Market Forecast Model
- Quality Assessment
- Research Models
- Introduction: Intravenous Immunoglobulin (IVIG)
- Executive Summary
- Global Market Scenario
- Segment Market Scenario
- Geographic Market Scenario
- COVID-19 Impact
- Competitive Landscape
- Market Dynamics
- Market Drivers
- Driver 1
- Driver 2
- Driver 3
- Driver 4
- Driver 5
- Market Restraint
- Restraint 1
- Restraint 2
- Restraint 3
- Restraint 4
- Market Opportunities
- Opportunity 1
- Opportunity 2
- Opportunity 3
- Opportunity 4
- Market Trends
- Trend 1
- Trend 2
- Trend 3
- Trend 4
- Market Challenges
- Challenge 1
- Challenge 2
- Challenge 3
- Challenge 4
- Market Drivers
- Market Environment Analysis
- Porter’s 5 Forces Analysis
- PESTEL Analysis
- Value Chain Analysis
- SWOT Analysis
- Benchmark
- COVID-19 Impact Analysis: Intravenous Immunoglobulin (IVIG) Market
- COVID-19: Overview
- COVID-19 Impact on the Global Market
- COVID-19 Impact on the Regional Markets
- Market Analysis by Technology
- Myasthenia Gravis
- Myasthenia Gravis Market Forecast, 2021-2029 (USD Million)
- Hypogammaglobulinemia
- Hypogammaglobulinemia Market Forecast, 2021-2029 (USD Million)
- Chronic Inflammatory demyelinating polyneuropathy (CIDP)
- Chronic Inflammatory demyelinating polyneuropathy (CIDP) Market Forecast, 2021-2029 (USD Million)
- Multifocal motor neuropathy
- Multifocal motor neuropathy Market Forecast, 2021-2029 (USD Million)
- Primary immunodeficiency diseases
- Idiopathic thrombocytopenic purpura (ITP) Market Forecast, 2021-2029 (USD Million)
- Inflammatory myopathies
- Inflammatory myopathies Market Forecast, 2021-2029 (USD Million)
- Specific antibody deficiency
- Specific antibody deficiency Market Forecast, 2021-2029 (USD Million)
- Guillain-Barre syndrome
- Guillain-Barre syndrome Market Forecast, 2021-2029 (USD Million)
- Others
- Others Market Forecast, 2021-2029 (USD Million)
- Myasthenia Gravis
- Market Analysis by End User
- Subcutaneous
- Subcutaneous Market Forecast, 2021-2029 (USD Million)
- Intravenous
- Intravenous Market Forecast, 2021-2029 (USD Million)
- Subcutaneous
- Regional Market Analysis
- Regional Market Trends
- Regional Market: Comparative Analysis
- North America Intravenous Immunoglobulin (IVIG) Market
- North America Intravenous Immunoglobulin (IVIG) Market
- North America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- S. Intravenous Immunoglobulin (IVIG) Market
- S. Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Canada Intravenous Immunoglobulin (IVIG) Market
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- S. Market Size and Forecast, 2021-2029 (USD Million)
- North America Market Size and Forecast, 2021-2029 (USD Million)
- North America Intravenous Immunoglobulin (IVIG) Market
- Europe Intravenous Immunoglobulin (IVIG) Market
- Europe Intravenous Immunoglobulin (IVIG) Market
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Germany Intravenous Immunoglobulin (IVIG) Market
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- UK Intravenous Immunoglobulin (IVIG) Market
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- France Intravenous Immunoglobulin (IVIG) Market
- France Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Spain Intravenous Immunoglobulin (IVIG) Market
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Italy Intravenous Immunoglobulin (IVIG) Market
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of Europe Intravenous Immunoglobulin (IVIG) Market
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- France Market Size and Forecast, 2021-2029 (USD Million)
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Europe Intravenous Immunoglobulin (IVIG) Market
- Asia Pacific Intravenous Immunoglobulin (IVIG) Market
- Asia Pacific Intravenous Immunoglobulin (IVIG) Market
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Japan Intravenous Immunoglobulin (IVIG) Market
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- China Intravenous Immunoglobulin (IVIG) Market
- China Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- India Intravenous Immunoglobulin (IVIG) Market
- India Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- South Korea Intravenous Immunoglobulin (IVIG) Market
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Market Size and Forecast by Device, 2021-2029 (USD Million)
- Australia Intravenous Immunoglobulin (IVIG) Market
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of Asia Pacific Intravenous Immunoglobulin (IVIG) Market
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- India Market Size and Forecast, 2021-2029 (USD Million)
- China Market Size and Forecast, 2021-2029 (USD Million)
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Intravenous Immunoglobulin (IVIG) Market
- Latin America Intravenous Immunoglobulin (IVIG) Market
- Latin America Intravenous Immunoglobulin (IVIG) Market
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Brazil Intravenous Immunoglobulin (IVIG) Market
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Mexico Intravenous Immunoglobulin (IVIG) Market
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Argentina Intravenous Immunoglobulin (IVIG) Market
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of Latin America Intravenous Immunoglobulin (IVIG) Market
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Intravenous Immunoglobulin (IVIG) Market
- MEA Intravenous Immunoglobulin (IVIG) Market
- MEA Intravenous Immunoglobulin (IVIG) Market
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- GCC Intravenous Immunoglobulin (IVIG) Market
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- South Africa Intravenous Immunoglobulin (IVIG) Market
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of MEA Intravenous Immunoglobulin (IVIG) Market
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Technology, 2021-2029 (USD Million)
- Market Size and Forecast by End User, 2021-2029 (USD Million)
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- MEA Intravenous Immunoglobulin (IVIG) Market
- Competitor Analysis
- Market Share Analysis, 2021 & 2029
- Competitive Mapping
- Key Players Market Place Analysis
- Major Recent Developments
- Company Profiles
- Baxter International Inc. (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Bayer AG (Germany)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Biotest AG (Germany)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- China Biologic Products, Inc. (China)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- CSL Limited (Australia)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Grifols, S.A. (Spain)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Kedrion Biopharma Inc. (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- LFB Biotechnologies (France)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Octapharma AG (Switzerland)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Takeda Pharmaceutical Company Limited (Japan)
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Company 11
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Company 12
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Company 13
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Company 14
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Company 15
- Company Snapshot
- Company Overview
- Financials
- Technology Benchmarking
- Recent Developments
- Others Prominent Players
- Baxter International Inc. (U.S.)
Conclusion & Recommendations